跳至主要内容
临床试验/JPRN-jRCT1031210331
JPRN-jRCT1031210331尚未招募2 期

Efficacy of Duloxetine for Chronic postsurgical Pain after Total Hip ArthroplastyA randomized controlled trial

ishi Masanori0 个研究点目标入组 100 人开始时间: 2021年9月22日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients who have osteoarthritis of hip
  • 2) Aged more than 20 years
  • 3) Persons who have not taken duloxetine or two weeks since last dose
  • 4) Written informed consent

排除标准

  • 1) Persons with a history of hypersensitivity to the duloxetine
  • 2) Persons administering monoamine oxidase (MAO) inhibitors
  • 3) Persons administering medicines that have a strong inhibitory effect on CYP1A2
  • 4) Persons with severe liver damage (ALAT or ASAT>100IU/L) , history of liver cirrhosis, or liver transplantation
  • 5) Persons with renal damage (eGFR<30mL/min), renal transplantation, or dialysis therapy
  • 6) Depression (HAM-D score > 7)
  • 7) Persons with alcohol or other dependence within 5 years
  • 8) Persons with severe cardiovascular disease
  • 9) Hyponatremia (<135 nmol/L)
  • 10) Persons with uncontrolled hypertension
  • 11) Patients with glaucoma, thyroid disease, or epilepsy
  • 12) Persons who are or may be pregnant
  • 13) Persons with a history of hypersensitivity to the Non-Steroidal Anti-Inflammatory Drugs or aspirin-induced asthma.
  • 14) Persons who are judged by the research-responsible (sharing) doctor to be inappropriate for participation in this research

研究者

发起方
ishi Masanori

相似试验